Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Stallings

Showing results (21-30 of 53) with videos related to

Pageof 6
Sort By:
Journal of Neurobiology|August 13, 2004
Loss of steroidogenic factor 1 alters cellular topography in the mouse ventromedial nucleus of the hypothalamusAline M Davis, Marianne L Seney, Nancy R Stallings, et al.
Molecular and Cellular Endocrinology|March 18, 2004
Tissue-specific knockouts of steroidogenic factor 1Liping Zhao, Marit Bakke, Neil A Hanley, et al.
Psychiatric Services (Washington, D.C.)|December 31, 2003
Association between cognitive functioning and employment status of persons with bipolar disorderFaith B Dickerson, John J Boronow, Cassie R Stallings, et al.
Schizophrenia Research|November 15, 2008
Double blind trial of adjunctive valacyclovir in individuals with schizophrenia who are seropositive for cytomegalovirusFaith B Dickerson, Cassie R Stallings, John J Boronow, et al.
Psychiatric Services (Washington, D.C.)|January 3, 2013
Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011Faith Dickerson, Catherine R Stallings, Andrea E Origoni, et al.
Molecular Endocrinology (Baltimore, Md.)|May 31, 2008
Steroidogenic factor 1 regulates expression of the cannabinoid receptor 1 in the ventromedial hypothalamic nucleusKi Woo Kim, Young-Hwan Jo, Liping Zhao, et al.
Schizophrenia Research|February 7, 2009
A double-blind trial of adjunctive allopurinol for schizophreniaFaith B Dickerson, Cassie R Stallings, Andrea E Origoni, et al.
Plos One|August 23, 2013
TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasisNancy R Stallings, Krishna Puttaparthi, Katherine J Dowling, et al.
Schizophrenia Research|November 5, 2002
Placebo response in a double-blind therapeutic supplementation trial in stabilized outpatients with schizophreniaFaith B Dickerson, John J Boronow, Cassie R Stallings, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 17, 2008
Differentiating nicotine- versus schizophrenia-associated decreases of the alpha7 nicotinic acetylcholine receptor transcript, CHRFAM7A, in peripheral blood lymphocytesEmily G Severance, Faith B Dickerson, Cassie R Stallings, et al.
Pageof 6

Showing results (21-30 of 53) with videos related to

Sort By:
Pageof 6
Journal of Neurobiology|August 13, 2004
Loss of steroidogenic factor 1 alters cellular topography in the mouse ventromedial nucleus of the hypothalamusAline M Davis, Marianne L Seney, Nancy R Stallings, et al.
Molecular and Cellular Endocrinology|March 18, 2004
Tissue-specific knockouts of steroidogenic factor 1Liping Zhao, Marit Bakke, Neil A Hanley, et al.
Psychiatric Services (Washington, D.C.)|December 31, 2003
Association between cognitive functioning and employment status of persons with bipolar disorderFaith B Dickerson, John J Boronow, Cassie R Stallings, et al.
Schizophrenia Research|November 15, 2008
Double blind trial of adjunctive valacyclovir in individuals with schizophrenia who are seropositive for cytomegalovirusFaith B Dickerson, Cassie R Stallings, John J Boronow, et al.
Psychiatric Services (Washington, D.C.)|January 3, 2013
Cigarette smoking among persons with schizophrenia or bipolar disorder in routine clinical settings, 1999-2011Faith Dickerson, Catherine R Stallings, Andrea E Origoni, et al.
Molecular Endocrinology (Baltimore, Md.)|May 31, 2008
Steroidogenic factor 1 regulates expression of the cannabinoid receptor 1 in the ventromedial hypothalamic nucleusKi Woo Kim, Young-Hwan Jo, Liping Zhao, et al.
Schizophrenia Research|February 7, 2009
A double-blind trial of adjunctive allopurinol for schizophreniaFaith B Dickerson, Cassie R Stallings, Andrea E Origoni, et al.
Plos One|August 23, 2013
TDP-43, an ALS linked protein, regulates fat deposition and glucose homeostasisNancy R Stallings, Krishna Puttaparthi, Katherine J Dowling, et al.
Schizophrenia Research|November 5, 2002
Placebo response in a double-blind therapeutic supplementation trial in stabilized outpatients with schizophreniaFaith B Dickerson, John J Boronow, Cassie R Stallings, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|December 17, 2008
Differentiating nicotine- versus schizophrenia-associated decreases of the alpha7 nicotinic acetylcholine receptor transcript, CHRFAM7A, in peripheral blood lymphocytesEmily G Severance, Faith B Dickerson, Cassie R Stallings, et al.
Pageof 6